News
Important Only
Gee Group Reports 9 Percent Drop in Q3
Key PointsConsolidated revenue (GAAP) declined 9% year over year to $24.5 million, with continued softness in contract staffing demand.Net loss from continuing operations (GAAP) narrowed sharply, as prior-year results included significant non-cash impairment charges in Q3 and 9M FY2024.Management pr...The Motley Fool
Wed, Aug 13
StandardAero Sales Jump 13 Percent
Key PointsGAAP revenue topped analyst estimates, rising 13.5% to $1,528.9 million in Q2 2025.GAAP net income grew sharply, reaching $67.7 million in Q2 2025—up over 1,150% from the prior year period.Management raised its FY2025 outlook, citing stronger segment performance and sustained demand.These ...The Motley Fool
Wed, Aug 13
Alto Neuroscience Posts Q2 Net Loss
Key PointsAlto Neuroscience (NYSE:ANRO) reported a net loss of $17.7 million (GAAP) in Q2 2025, with EPS of $(0.65) (GAAP).No revenue was reported, as the company remains in the clinical-stage development phase.Cash reserves stood at $148.1 million at the end of Q2 2025, with management projecting f...The Motley Fool
Wed, Aug 13
Roadzen Posts 22% Q1 Revenue Gain
Key PointsRoadzen reported record revenue for Q1 FY2026 but missed analyst estimates by 48.7% (GAAP), with GAAP revenue was $10.9 million versus a GAAP forecast of $21.262 million.Gross margin was 58.9%, a 19.7 percentage point improvement over the prior year period, and net loss (GAAP) fell sharply...The Motley Fool
Wed, Aug 13
Coherent falls after forecasting quarterly revenue below estimates
** Shares of laser and optical devices maker Coherent COHR.N fall 17.4% to $94.20 in after-hours trading** Company forecasts first-quarter revenue between $1.46 billion and $1.60 billion, the midpoint of which is below analysts' average estimate of $1.54 billion, according to data compiled by LS...Reuters
Wed, Aug 13
Immuneering Posts Narrower Loss in Q2
Key PointsGAAP net loss per share narrowed to $0.40 in Q2 2025, This result substantially exceeded analyst expectations for the quarter.Strong clinical progress for lead drug atebimetinib, with a 94% six-month overall survival rate in first-line pancreatic cancer as of May 26, 2025.Cash balance stoo...The Motley Fool
Wed, Aug 13
Red Robin Q2 Margins Rise on Labor Gains
Red Robin Gourmet Burgers(NASDAQ:RRGB) reported fiscal second quarter 2025 results on Aug. 13, 2025, with GAAP revenues of $283.7 million, a comparable restaurant revenue decline of 3.2%, and a 270 basis point year-over-year improvement in restaurant-level operating profit margin, led by labor effic...The Motley Fool
Wed, Aug 13
Dolphin Entertainment Reports Record Q2
Dolphin Entertainment(NASDAQ:DLPN) announced its results for the second quarter ended June 30, 2025, on August 13, 2025, achieving record revenue of $14.1 million, up 23% year-over-year, and positive adjusted operating income of approximately $628,000, compared to a loss in the prior year period. Th...The Motley Fool
Wed, Aug 13
Solventum dips as 3M to slice stake
** Shares of medical device maker Solventum SOLV.N down 1.2% to $73.50 post-market after secondary offering news ** SOLV launches offering of 8.8 mln shares to be offloaded by 3M MMM.N ** Goldman Sachs and BofA are underwriters ** MMM owns ~34.37 mln SOLV shares for 19.8% stake, accor...Reuters
Wed, Aug 13
Jasper Reports Wider Loss in Fiscal Q2
Key PointsJasper Therapeutics (NASDAQ:JSPR) reported a GAAP loss per share of $1.74 for Q2 2025.Research and development expenses (GAAP) nearly doubled to $21.2 million in Q2 2025 from $11.3 million in Q2 2024.No revenue was generated during the quarter; Cash and cash equivalents dropped to $39.5 mi...The Motley Fool
Wed, Aug 13
Boston Omaha Posts 4% Sales Gain
Key PointsEarnings per share (GAAP) were $(0.07) in Q2 2025, missing the GAAP analyst estimate of $0.03.Revenue (GAAP) rose 4.1% in Q2 2025 versus Q2 2024 but missed the GAAP consensus estimate of $29.4 million.Operating losses narrowed in Q2 2025, but no forward guidance was given by management.The...The Motley Fool
Wed, Aug 13
Boxlight Sales Drop 20 Percent
Key PointsRevenue (GAAP) in Q2 2025 rose to $30.9 million, exceeding analyst expectations by 13.1%, but was down 19.9% compared to Q2 2024.Earnings per share (GAAP) for Q2 2025 was $(1.53), missing estimatesBoxlight failed to comply with its credit agreement covenants for four consecutive months—Apr...The Motley Fool
Wed, Aug 13
HeartBeam Cuts Costs Awaits FDA Decision
HeartBeam (NASDAQ:BEAT) reported its Q2 2025 results on July 16, 2025, reaffirming key regulatory and commercial milestones and announcing a 23% sequential decrease in cash burn to $3.4 million. The company finished with a $5.1 million cash balance and remains on track for FDA clearance of its 12-le...The Motley Fool
Wed, Aug 13
Why Novo Nordisk Stock Topped the Market Today
Key PointsAn analyst upgraded his recommendation on the Danish pharmaceutical company.In his view, the Wegovy developer now ranks as a neutral.10 stocks we like better than Novo Nordisk › Novo Nordisk (NYSE: NVO) is quite the divisive stock among both investors and analysts these days. Although its ...The Motley Fool
Wed, Aug 13
Xos Reports Record Q2 Revenue Growth
Key PointsRecord revenue and deliveries: GAAP revenue rose to $18.4 million, with 135 vehicles delivered, both all-time highs for the company.Gross margin (GAAP) declined to 8.8%, down from 13.1% in Q2 2024 as product mix and cost factors weighed on profitability.The full-year 2025 non-GAAP operatin...The Motley Fool
Wed, Aug 13
